Purinergic Signalling: What is Missing and Needed Next? The Use of Transgenic Mice, Crystallographic Analysis and MicroRNA

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|11|6|751-767

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.11, Iss.6, 2012-09, pp. : 751-767

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA Therapeutics: the Next Magic Bullet?

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 6, 2015-05 ,pp. : 467-474

Bentham Science Publishers

Access to resources Recommend Favorite

Host-directed therapy of tuberculosis: what is in it for microRNA?

By Iannaccone Marco   Dorhoi Anca   Kaufmann Stefan HE  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 5, 2014-05 ,pp. : 491-494

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA in Osteoarthritis

By Yu C   Chen W-P   Wang X-H  

The Journal of International Medical Research, Vol. 39, Iss. 1, 2011-01 ,pp. : 1-9

Field House Publishing

Access to resources Recommend Favorite

Use of transgenic mice in UDP-glucuronosyltransferase (UGT) studies

By Ou Zhimin   Huang Min   Zhao Lizi   Xie Wen  

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 123-131

Informa Healthcare

Access to resources Recommend Favorite

MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for MicroRNA Mediated Therapeutics

By  

Current Pharmaceutical Design, Vol. 15, Iss. 4, 2009-02 ,pp. : 456-462

Bentham Science Publishers

Access to resources Recommend Favorite